Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules (Q30882285)

27 June 2017

Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules (English)

1 reference

27 June 2017

Wang W

1

1 reference

27 June 2017

Préville P

2

1 reference

27 June 2017

Morin N

3

1 reference

27 June 2017

Mounir S

4

1 reference

27 June 2017

Cai W

5

1 reference

27 June 2017

Siddiqui MA

6

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Bioorganic & Medicinal Chemistry Letters

27 June 2017

1 reference

27 June 2017

10

1 reference

27 June 2017

11

1 reference

27 June 2017

1151-1154

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900217-1

7 January 2021

Candidate targets for hepatitis C virus-specific antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900217-1

7 January 2021

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900217-1

7 January 2021

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900217-1

7 January 2021

Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900217-1

7 January 2021

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900217-1

7 January 2021

10.1016/S0960-894X(00)00217-1

Identifiers

DOI

1 reference

27 June 2017

1 reference